Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Depreciation & Amortization (CF) (2019 - 2026)

Biodesix filings provide 8 years of Depreciation & Amortization (CF) readings, the most recent being $1.4 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 3.06% to $1.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.6 million, a 2.92% decrease, with the full-year FY2025 number at $5.7 million, down 1.78% from a year prior.
  • Depreciation & Amortization (CF) hit $1.4 million in Q1 2026 for Biodesix, up from $1.4 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.5 million in Q3 2024 to a low of $782000.0 in Q3 2023.
  • Median Depreciation & Amortization (CF) over the past 5 years was $1.4 million (2025), compared with a mean of $1.2 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): fell 13.55% in 2023 and later skyrocketed 90.92% in 2024.
  • Biodesix's Depreciation & Amortization (CF) stood at $898000.0 in 2022, then increased by 8.8% to $977000.0 in 2023, then soared by 48.31% to $1.4 million in 2024, then fell by 4.28% to $1.4 million in 2025, then rose by 0.65% to $1.4 million in 2026.
  • The last three reported values for Depreciation & Amortization (CF) were $1.4 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025) per Business Quant data.